AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATE IN HEMOPHILIA-B PATIENTS UNDERGOING SURGICAL-PROCEDURES
Authors: SHAPIRO AD WHITE GC KIM HC LUSHER JM BERGMAN GE
Citation: Ad. Shapiro et al., EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATE IN HEMOPHILIA-B PATIENTS UNDERGOING SURGICAL-PROCEDURES, Haemophilia, 3(4), 1997, pp. 247-253
LACK OF IMMUNE-RESPONSE TO MOUSE IGC IN PREVIOUSLY UNTREATED HEMOPHILIA-A AND HEMOPHILIA-B PATIENTS TREATED WITH MONOCLONAL-ANTIBODY PURIFIED FACTOR-VIII AND FACTOR-IX PREPARATIONS
Authors: DAVIS HM NASH DW CLYMER MD FRIGO ML BERGMAN GE
Citation: Hm. Davis et al., LACK OF IMMUNE-RESPONSE TO MOUSE IGC IN PREVIOUSLY UNTREATED HEMOPHILIA-A AND HEMOPHILIA-B PATIENTS TREATED WITH MONOCLONAL-ANTIBODY PURIFIED FACTOR-VIII AND FACTOR-IX PREPARATIONS, Haemophilia, 3(2), 1997, pp. 102-107
CONTINUOUS-INFUSION OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX IN HEMOPHILIA-B SURGICAL, TRAUMA, OR SEVERE SPONTANEOUS HEMORRHAGE PATIENTS
Authors: KURCZYNSKI E LEISSINGER C BERGMAN GE
Citation: E. Kurczynski et al., CONTINUOUS-INFUSION OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX IN HEMOPHILIA-B SURGICAL, TRAUMA, OR SEVERE SPONTANEOUS HEMORRHAGE PATIENTS, Thrombosis and haemostasis, 1997, pp. 214-214
MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX DOSING TRENDS GIVEN FOR PREVIOUSLY UNTREATED PATIENTS (PUPS)
Authors: SHAPIRO A BERGMAN GE
Citation: A. Shapiro et Ge. Bergman, MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX DOSING TRENDS GIVEN FOR PREVIOUSLY UNTREATED PATIENTS (PUPS), Thrombosis and haemostasis, 1997, pp. 216-216
SAFETY AND EFFICACY OF STIMATE(R) (DESMOPRESSIN ACETATE, 1.5 MG ML) NASAL SPRAY IN PATIENTS WITH MILD HEMOPHILIA-A/
Authors: CORNELL C GILL J BERGMAN GE
Citation: C. Cornell et al., SAFETY AND EFFICACY OF STIMATE(R) (DESMOPRESSIN ACETATE, 1.5 MG ML) NASAL SPRAY IN PATIENTS WITH MILD HEMOPHILIA-A/, Thrombosis and haemostasis, 1997, pp. 998-998
SAFETY AND EFFICACY OF STIMATE(R) (DESMOPRESSIN ACETATE, 1.5 MG ML) NASAL SPRAY IN PATIENTS WHO ARE HEMOPHILIA-A CARRIERS/
Authors: KOBRINSKY N BERGMAN GE
Citation: N. Kobrinsky et Ge. Bergman, SAFETY AND EFFICACY OF STIMATE(R) (DESMOPRESSIN ACETATE, 1.5 MG ML) NASAL SPRAY IN PATIENTS WHO ARE HEMOPHILIA-A CARRIERS/, Thrombosis and haemostasis, 1997, pp. 999-999
HAEMATE(R) DOSING TRENDS AMONG 97 CANADIAN VON-WILLEBRAND-DISEASE (VWD) PATIENTS
Authors: PAI M ROBINSON S TEITEL J BERGMAN GE
Citation: M. Pai et al., HAEMATE(R) DOSING TRENDS AMONG 97 CANADIAN VON-WILLEBRAND-DISEASE (VWD) PATIENTS, Thrombosis and haemostasis, 1997, pp. 2098-2098
REPORT OF THE EFFICACY AND SAFETY OF HAEMATE(R)-P IN CANADIAN VON-WILLEBRAND-DISEASE (VWD) PATIENTS
Authors: BLANCHETTE V ISRAELS SJ AKABUTU J BERGMAN GE
Citation: V. Blanchette et al., REPORT OF THE EFFICACY AND SAFETY OF HAEMATE(R)-P IN CANADIAN VON-WILLEBRAND-DISEASE (VWD) PATIENTS, Thrombosis and haemostasis, 1997, pp. 2100-2100
VIRAL SAFETY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-VIII - RESULTS FROM PREVIOUSLY UNTREATED PATIENTS (PUPS)
Authors: PHILIPP CS MAUSERBUNSCHOTEN E SAVIDGE G BERGMAN GE
Citation: Cs. Philipp et al., VIRAL SAFETY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-VIII - RESULTS FROM PREVIOUSLY UNTREATED PATIENTS (PUPS), Thrombosis and haemostasis, 1997, pp. 2647-2647
COMPARISON OF INTRAVENOUS (IV) AND INTRANASAL (IN) DESMOPRESSIN ACETATE (DDAVP) IN PATIENTS WEIGHING LESS-THAN-OR-EQUAL-TO-50 KG WITH MILD HEMOPHILIA-A (HA) OR MILD-TO-MODERATE VON-WILLENBRAND-DISEASE (VWD, TYPE-1)
Authors: GILL JC OTTUM M BERGMAN GE
Citation: Jc. Gill et al., COMPARISON OF INTRAVENOUS (IV) AND INTRANASAL (IN) DESMOPRESSIN ACETATE (DDAVP) IN PATIENTS WEIGHING LESS-THAN-OR-EQUAL-TO-50 KG WITH MILD HEMOPHILIA-A (HA) OR MILD-TO-MODERATE VON-WILLENBRAND-DISEASE (VWD, TYPE-1), Thrombosis and haemostasis, 1997, pp. 2840-2840
SAFETY AND EFFICACY OF STIMATE(R) (DESMOPRESSIN ACETATE, 1.5 MG ML) NASAL SPRAY IN PATIENTS WITH MILD-TO-MODERATE VON-WILLEBRAND-DISEASE (VWD)/
Authors: BECTON D THOMPSON AR BERGMAN GE
Citation: D. Becton et al., SAFETY AND EFFICACY OF STIMATE(R) (DESMOPRESSIN ACETATE, 1.5 MG ML) NASAL SPRAY IN PATIENTS WITH MILD-TO-MODERATE VON-WILLEBRAND-DISEASE (VWD)/, Thrombosis and haemostasis, 1997, pp. 2842-2842
SAFETY AND EFFICACY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATE IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-B
Authors: SHAPIRO AD RAGNI MV LUSHER JM CULBERT S KOERPER MA BERGMAN GE HANNAN MM
Citation: Ad. Shapiro et al., SAFETY AND EFFICACY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATE IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-B, Thrombosis and haemostasis, 75(1), 1996, pp. 30-35
EVALUATION OF THE SAFETY AND EFFICACY OF STIMATE(R) (DESMOPRESSIN ACETATE, 1.5 MG ML) NASAL SPRAY UTILIZING INTERACTIVE VOICE RESPONSE (IVE) TECHNOLOGY/
Authors: HANNAN MM BERGMAN GE CLARK PE
Citation: Mm. Hannan et al., EVALUATION OF THE SAFETY AND EFFICACY OF STIMATE(R) (DESMOPRESSIN ACETATE, 1.5 MG ML) NASAL SPRAY UTILIZING INTERACTIVE VOICE RESPONSE (IVE) TECHNOLOGY/, Blood, 88(10), 1996, pp. 3022-3022
THE REMOVAL OF HEPATITIS-C VIRAL GENOMIC MATERIAL DURING THE MANUFACTURING PROCESS OF INTRAVENOUS IMMUNE GLOBULIN
Authors: CHANDRA S JEROME CP COWDEN D WEEKS R FLANIGAN E FELDMAN F BERGMAN GE LIN C
Citation: S. Chandra et al., THE REMOVAL OF HEPATITIS-C VIRAL GENOMIC MATERIAL DURING THE MANUFACTURING PROCESS OF INTRAVENOUS IMMUNE GLOBULIN, Blood, 88(10), 1996, pp. 3087-3087
VIRAL SAFETY OF PASTEURIZED INTRAVENOUS IMMUNE GLOBULIN
Authors: CHANDRA S CAVANAUGH J YERRAM N BERGMAN GE FLANIGAN E
Citation: S. Chandra et al., VIRAL SAFETY OF PASTEURIZED INTRAVENOUS IMMUNE GLOBULIN, Blood, 88(10), 1996, pp. 3088-3088
VIRAL SAFETY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX - RESULTS FROMPREVIOUSLY UNTREATED PATIENTS (PUPS)
Authors: SHAPIRO A LUSHER J BERGMAN GE
Citation: A. Shapiro et al., VIRAL SAFETY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX - RESULTS FROMPREVIOUSLY UNTREATED PATIENTS (PUPS), Blood, 88(10), 1996, pp. 1297-1297
EVALUATION OF THE SAFETY AND EFFICACY OF STIMATE(R) (DESMOPRESSIN ACETATE, 1.5 MG ML) NASAL SPRAY IN A PHASE 4 MULTICENTER TRIAL/
Authors: HANNAN MM BERGMAN GE CLARK PE
Citation: Mm. Hannan et al., EVALUATION OF THE SAFETY AND EFFICACY OF STIMATE(R) (DESMOPRESSIN ACETATE, 1.5 MG ML) NASAL SPRAY IN A PHASE 4 MULTICENTER TRIAL/, Blood, 88(10), 1996, pp. 1311-1311
EVALUATION OF STIMATE(R) (DESMOPRESSIN ACETATE) NASAL SPRAY, 1.5 MG ML IN PATIENTS WEIGHING LESS-THAN-OR-EQUAL-TO-50 KG WITH MILD HEMOPHILIA-A OR MILD-TO-MODERATE VON-WILLEBRAND DISEASE (TYPE-1)/
Authors: GILL JC OTTUM M BERGMAN GE
Citation: Jc. Gill et al., EVALUATION OF STIMATE(R) (DESMOPRESSIN ACETATE) NASAL SPRAY, 1.5 MG ML IN PATIENTS WEIGHING LESS-THAN-OR-EQUAL-TO-50 KG WITH MILD HEMOPHILIA-A OR MILD-TO-MODERATE VON-WILLEBRAND DISEASE (TYPE-1)/, Blood, 88(10), 1996, pp. 1754-1754
SAFETY AND EFFICACY OF MONOCLONAL ANTIBODY-PURIFIED FACTOR-IX CONCENTRATE FOR MANAGEMENT OF BLEEDING AND SURGICAL PROPHYLAXIS IN PREVIOUSLYTREATED CHILDREN WITH HEMOPHILIA-B
Authors: KURCZYNSKI E LUSHER JM PITEL P SHAPIRO AD BERGMAN GE
Citation: E. Kurczynski et al., SAFETY AND EFFICACY OF MONOCLONAL ANTIBODY-PURIFIED FACTOR-IX CONCENTRATE FOR MANAGEMENT OF BLEEDING AND SURGICAL PROPHYLAXIS IN PREVIOUSLYTREATED CHILDREN WITH HEMOPHILIA-B, International journal of pediatric hematology/oncology, 2(3), 1995, pp. 211-216
SAFETY OF HIGH-DOSES OF A MONOCLONAL ANTIBODY-PURIFIED FACTOR-IX CONCENTRATE
Authors: WARRIER I KASPER CK WHITE GC SHAPIRO AD BERGMAN GE
Citation: I. Warrier et al., SAFETY OF HIGH-DOSES OF A MONOCLONAL ANTIBODY-PURIFIED FACTOR-IX CONCENTRATE, American journal of hematology, 49(1), 1995, pp. 92-94
SAFETY OF MONOCLONAL ANTIBODY-PURIFIED FACTOR-IX IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-B
Authors: SHAPIRO A BERGMAN GE
Citation: A. Shapiro et Ge. Bergman, SAFETY OF MONOCLONAL ANTIBODY-PURIFIED FACTOR-IX IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-B, Thrombosis and haemostasis, 73(6), 1995, pp. 1021-1021
SAFETY AND EFFICACY OF MONOCLONAL-ANTIBODY (MAB)-PURIFIED FACTOR-IX FOR PROPHYLAXIS AGAINST BLEEDING IN HEMOPHILIA-B PATIENTS UNDERGOING SURGICAL-PROCEDURES
Authors: SHAPIRO A WHITE GC PITEL P BERGMAN GE
Citation: A. Shapiro et al., SAFETY AND EFFICACY OF MONOCLONAL-ANTIBODY (MAB)-PURIFIED FACTOR-IX FOR PROPHYLAXIS AGAINST BLEEDING IN HEMOPHILIA-B PATIENTS UNDERGOING SURGICAL-PROCEDURES, Thrombosis and haemostasis, 73(6), 1995, pp. 1022-1022
VARIABILITY OF IN-VIVO RECOVERY OF FACTOR-IX AFTER INFUSION OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATES IN PATIENTS WITH HEMOPHILIA-B
Authors: WHITE GC SHAPIRO AD KURCZYNSKI EM KIM HC BERGMAN GE BENJAMIN L BROOKS P CORNELL NJ CZAPEK E DAVIS RT DIMICHELE D DJULBEGOVIC B GILL JC GOLDSMITH J GORDON ME GREEN D GREENBERG S GRIBBLE J HILGARTNER M HODDER F HUTTER JJ JANCO R KASPER C KESSLER C LUSHER J MARTINOWITZ U OPENSHAW TH PHILLIPS M PITEL P POTOLSKY A PRESTON FE RAUSEN A SAVIDGE G SEXAUER C SHURAFA M SMITH G SWEENEY J TELFORD M WILDE J WILSON W
Citation: Gc. White et al., VARIABILITY OF IN-VIVO RECOVERY OF FACTOR-IX AFTER INFUSION OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATES IN PATIENTS WITH HEMOPHILIA-B, Thrombosis and haemostasis, 73(5), 1995, pp. 779-784
TRANSMISSION OF HEPATITIS-C VIRUS BY MONOCLONAL-PURIFIED VIRAL-ATTENUATED FACTOR-VIII CONCENTRATE
Authors: BERGMAN GE
Citation: Ge. Bergman, TRANSMISSION OF HEPATITIS-C VIRUS BY MONOCLONAL-PURIFIED VIRAL-ATTENUATED FACTOR-VIII CONCENTRATE, Lancet, 346(8985), 1995, pp. 1296-1297
CONCOMITANT TREATMENT WITH FACTOR-IX CONCENTRATES AND ANTIFIBRINOLYTICS IN HEMOPHILIA-B
Authors: DJULBEGOVIC B HANNAN MM BERGMAN GE
Citation: B. Djulbegovic et al., CONCOMITANT TREATMENT WITH FACTOR-IX CONCENTRATES AND ANTIFIBRINOLYTICS IN HEMOPHILIA-B, Acta haematologica, 94, 1995, pp. 43-48
Risultati: 1-25 | 26-31